||P. Marrack, J. Kappler, and B.L. Kotzin, "Autoimmune disease: why and where it occurs," Nature Medicine, vol. 7, pp. 899-905, 2001.|
 M. Palladino, F. Bahjat, E. Theodorakis, and L. Moldawer, "Anti-TNF-alpha therapies: the next generation," Nature Reviews Drug Discovery, vol. 2, pp. 736-46, Sep 2003.
 Z. Huang, Z. Zhang, Y. Zha, J. Liu, Y. Jiang, Y. Yang, J. Shao, X. Sun, X. Cai, Y. Yin, J. Chen, L. Dong, and J. Zhang, "The effect of targeted delivery of anti-TNF-α oligonucleotide into CD169+ macrophages on disease progression in lupus-prone MRL/lpr mice," Biomaterials, vol. 33, pp. 7605-7612, 2012.
 B. Layek and J. Singh, "Cell penetrating peptide conjugated polymeric micelles as a high performance versatile nonviral gene carrier," Biomacromolecules, vol. 14, pp. 4071-81, 2013.
 M. Elsabahy, A. Nazarali, and M. Foldvari, "Non-Viral Nucleic Acid Delivery: Key Challenges and Future Directions," Current Drug Delivery, vol. 8, pp.235-244, 2011.
 M. Elsabahy, A. Nazarali, and M. Foldvari, "Non-Viral Nucleic Acid Delivery: Key Challenges and Future Directions," vol. 8, 2011.
 H. Amand, B. Norden, and K. Fant, "Functionalization with C-terminal cysteine enhances transfection efficiency of cell-penetrating peptides through dimer formation," Biochem Biophys Res Commun, vol. 418, pp. 469-74, 2012.
 M. Moser and O. Leo, "Key concepts in immunology," Vaccine, vol. 28 Suppl 3, pp. C2-13, 2010.
 K. Murphy and C. Weaver, Janeway′s immunobiology: Garland Science, 2016.
 J. Parkin and B. Cohen, "An overview of the immune system," The Lancet, vol. 357, pp. 1777-1789, 2001.
 A. Hajeer and I. Hutchinson, "TNF-α Gene Polymorphism: Clinical and Biological Implications," Microscopy Research and Technique, pp. 216–228, 2000.
 W. Fiers, "Tumor necrosis factor Characterization at the molecular, cellular and in vivo level ." Federation of European Biochemical Societies vol. 285, pp. 199-212 1992.
 H. Gordon, G. Kucera, R. Salvo, and J. Boss, "Tumor necrosis factor induces genes involved in inflammation, cellular and tissue repair, and metabolism in murine fibroblasts," The Journal of Immunology, vol. 148, pp. 4021-4027, 1992.
 D.J. Gould, C. Bright, and Y. Chernajovsky, "Inhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmid," Arthritis Research & Therapy, vol. 6, pp. R103-13, 2004.
 M. Stephenson and P. Zamecnik, "Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide," Proceedings of the National Academy of Sciences of the United States of America, vol. 75, pp. 285-288, 1978.
 P.C. Zamecnik and M.L. Stephenson, "Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide," Proceedings of the National Academy of Sciences of the United States of America, vol. 75, pp. 280-284, 1978.
 J. Kurreck, "Antisense technologies," European Journal of Biochemistry, vol. 270, pp. 1628-1644, 2003.
 A.d. Fougerolles, H. Vornlocher, J. Maraganore, and J. Lieberman, "Interfering with disease: a progress report on siRNA-based therapeutics," Nature Reviews Drug Discovery, vol. 6, pp. 443-453, 2007.
 D. Grimm and M. Kay, "Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?," The Journal of Clinical Investigation, vol. 117, pp. 3633-3641, 2007.
 T. Doerks, R. Copley, J. Schultz, C. Ponting, and P. Bork, "Systematic identification of novel protein domain families associated with nuclear functions," Genome Research, vol. 12, pp. 47-56, 2002.
 E. Bernstein, A. Caudy, S. Hammond, and G. Hannon, "Role for a bidentate ribonuclease in the initiation step of RNA interference," Nature, vol. 409, pp. 363-366, 2001.
 D. Yang, H. Lu, and J. Erickson, "Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during RNAi in Drosophila embryos," Current Biology, vol. 10, pp. 1191-1200, 2000.
 J. Martinez, A. Patkaniowska, H. Urlaub, R. Lührmann, and T. Tuschl, "Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi," Cell, vol. 110, pp. 563-574, 2002.
 T. Dowler, D. Bergeron, A. Tedeschi, L. Paquet, N. Ferrari, and M. Damha, "Improvements in siRNA properties mediated by 2′-deoxy-2′-fluoro-β-d-arabinonucleic acid (FANA)," Nucleic Acids Research, vol. 34, pp. 1669-1675, 2006.
 J. Wang, Z. Lu, M. Wientjes, and J. Au, "Delivery of siRNA Therapeutics: Barriers and Carriers," The American Association of Pharmaceutical Scientists Journal, vol. 12, pp. 492-503, 2010.
 Y. Lee, K. Jeon, J. Lee, S. Kim, and V. Kim, "MicroRNA maturation: stepwise processing and subcellular localization," The European Molecular Biology OrganizationJournal, vol. 21, pp. 4663-4670, 2002.
 E. Lund, S. Güttinger, A. Calado, J. Dahlberg, and U. Kutay, "Nuclear Export of MicroRNA Precursors," Science, vol. 303, pp. 95-98, 2004.
 R. Yi, Y. Qin, I. Macara, and B. Cullen, "Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs," Genes & Development, vol. 17, pp. 3011-3016, 2003.
 Y. Zeng and B. Cullen, "Structural requirements for pre-microRNA binding and nuclear export by Exportin 5," Nucleic Acids Research, vol. 32, pp. 4776-4785, 2004.
 Y. Lee, C. Ahn, J. Han, H. Choi, J. Kim, J. Yim, J. Lee, P. Provost, O. Radmark, S. Kim, and V. Kim, "The nuclear RNase III Drosha initiates microRNA processing," Nature, vol. 425, pp. 415-419, 2003.
 S. Sassen, E. Miska, and C. Caldas, "MicroRNA—implications for cancer," Virchows Archiv, vol. 452, pp. 1-10, 2008.
 P. Paddison, A. Caudy, E. Bernstein, G. Hannon, and D. Conklin, "Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells," Genes & Development, vol. 16, pp. 948-958, 2002.
 Y. Chen, G. Cheng, and R. Mahato, "RNAi for Treating Hepatitis B Viral Infection," Pharmaceutical Research, vol. 25, pp. 72-86, 2008.
 K. Karikó, P. Bhuyan, J. Capodici, and D. Weissman, "Small Interfering RNAs Mediate Sequence-Independent Gene Suppression and Induce Immune Activation by Signaling through Toll-Like Receptor 3," The Journal of Immunology, vol. 172, pp. 6545-6549, 2004.
 G. Deleavey and M. Damha, "Designing chemically modified oligonucleotides for targeted gene silencing," Chemistry and Biology, vol. 19, pp. 937-54, 2012.
 M. Mansoor and A. Melendez, "Advances in Antisense Oligonucleotide Development for Target Identification, Validation, and as Novel Therapeutics," Gene Regulation and Systems Biology, vol. 2, pp. 275-295, 2008.
 J. Chan, S. Lim, and W. Wong, "Antisense Oligonucleotides:From Design to Therapeutic Application," Clinical and Experimental Pharmacology and Physiology, vol. 33, pp. 533-540, 2006.
 P. Sazani and R. Kole, "Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing," Journal of Clinical Investigation, vol. 112, pp. 481-486, 2003.
 E. Dinç, "Antisense Oligodeoxynucleotide Technology: A Novel Tool for Gene Silencing in Higher Plants," Institute of Plant Biology Biological Research Centre Hungarian Academy of Sciences Doctoral School of Biology University of Szeged 2012.
 L. Dong, S. Xia, Y. Luo, H. Diao, J. Zhang, J. Chen, and J. Zhang, "Targeting delivery oligonucleotide into macrophages by cationic polysaccharide from Bletilla striata successfully inhibited the expression of TNF-α," Journal of Controlled Release, vol. 134, pp. 214-220, 2009.
 F. Eckstein, "A dinucleoside phosphorothioate," Tetrahedron Letters, vol. 8, pp. 1157-1160, 1967.
 F. Eckstein, "Nucleoside phosphorothioates," Journal of the American Chemical Society, vol. 92, pp. 4718-4723, 1970.
 Y.S. Sanghvi, "A Status Update of Modified Oligonucleotides for Chemotherapeutics Applications," in Current Protocols in Nucleic Acid Chemistry, ed: John Wiley & Sons, Inc., 2001.
 T. Aboul-Fadl, "Antisense Oligonucleotides: The State of the Art," Current Medicinal Chemistry, vol. 12, pp. 2193-2214, 2005.
 B. Yu, X. Zhao, L. Lee, and R. Lee, "Targeted Delivery Systems for Oligonucleotide Therapeutics," The American Association of Pharmaceutical Scientists Journal, vol. 11, pp. 195-203, 2009.
 A. Koirala, S. Conley, and M. Naash, "A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium," Biomaterials, vol. 34, pp. 7158-7167, 2013.
 Y. He, G. Cheng, L. Xie, Y. Nie, B. He, and Z. Gu, "Polyethyleneimine/DNA polyplexes with reduction-sensitive hyaluronic acid derivatives shielding for targeted gene delivery," Biomaterials, vol. 34, pp. 1235-1245, 2013.
 M. Xun, Y. Xiao, J. Zhang, Y. Liu, Q. Peng, Q Guo, W. Wu, Y. Xu, and X. Yu, "Low molecular weight PEI-based polycationic gene vectors via Michael addition polymerization with improved serum-tolerance," Polymer, vol. 65, pp. 45-54, 2015.
 B. Urban-Klein, S. Werth, S. Abuharbeid, F. Czubayko, and A. Aigner, "RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo," Gene therapy, vol. 12, pp. 461-466, 2004.
 A. Khan, M. Benboubetra, P. Sayyed, K.W. Ng, S. Fox, G. Beck, I. Benter, and S. Akhtar, "Sustained Polymeric Delivery of Gene Silencing Antisense ODNs, siRNA, DNAzymes and Ribozymes: In Vitro and In Vivo Studies," Journal of Drug Targeting, vol. 12, pp. 393-404, 2004.
 P. Cullis, M. Hope, and C. Tilcock, " Lipid Polymorphism and the Roles of Lipid in Membranes," Chemistry and Physics of Lipids pp. 127-144, 1986.
 H. Farhood, N. Serbina, and L. Huang, "The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer," Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1235, pp. 289-295, 1995.
 T. Allen and A. Chonn, "Large unilamellar liposomes with low uptake into the reticuloendothelial system," Federation of European Biochemical Societies, vol. 223, pp. 42-46, 1987.
 P. Hug and R. Sleight, "Liposomes for the transformation of eukaryotic cells," Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1097, pp. 1-17, 1991.
 W. Zauner, M Ogris, and E. Wagner, "Polylysine-Based Transfection Systems Utilizing Receptor-Mediated Delivery.," Advanced Drug Delivery Reviews vol. 30, p. 97, 1998.
 J. Rothbard, E. Kreider, C. VanDeusen, L. Wright, B. Wylie, and P. Wender, "Ariginine-Rich Molecular Transporters for Drug Delivery:Role of Backbone Spacing in Cellular Uptake.," Journal of Medicinal Chemistry vol. 45, p. 3612, 2002.
 C. Pichon, C. Gonçalves, and P. Midoux, "Histidine-Rich Peptides and Polymers for Nuclei Acids Delivery.," Advanced Drug Delivery Reviews, vol. 53, p. 75, 2001.
 P. Midoux, C. Pichon, J. Yaouanc, and P. Jaffrès, "Chemical Vectors for Gene Delivery:A Current Review on Polymers,Peptides and Lipids Containing Histidine or Imidazole As Nuclei Acids Carriers.," British Journal of Pharmacology, vol. 157, p. 166, 2009.
 W. Seow and Y. Yang, "A Class of Cationic Triblock Amphiphilic Oligopeptides as Efficient Gene-Delivery Vectors.," Advanced Materials vol. 21, p. 86, 2009.
 D. Derossi, S. Calvet, A. Trembleau, A. Brunissen, G. Chassaing, and A. Prochiantz, "Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent," Journal of Biological Chemistry, vol. 271, pp. 18188-18193, 1996.
 K. Matsuzaki, S. Yoneyama, O. Murase, and K. Miyajima, "Transbilayer Transport of Ions and Lipids Coupled with Mastoparan X Translocation," Biochemistry, vol. 35, pp. 8450-8456, 1996.
 Y. Pouny, D. Rapaport, A. Mor, P. Nicolas, and Y. Shai, "Interaction of antimicrobial dermaseptin and its fluorescently labeled analogs with phospholipid membranes," Biochemistry, vol. 31, pp. 12416-12423, 1992.
 M. Lee, W. Hung, F. Chen, and H. Huang, "Many-Body Effect of Antimicrobial Peptides: On the Correlation Between Lipid′s Spontaneous Curvature and Pore Formation," Biophysical Journal, vol. 89, pp. 4006-4016.
 S. Futaki, "Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms," International Journal of Pharmaceutics, vol. 245, pp. 1-7, 2002.
 A. Astriab-Fisher, D. Sergueev, M. Fisher, B.R. Shaw, and R. Juliano, "Antisense inhibition of P-glycoprotein expression using peptide–oligonucleotide conjugates," Biochemical Pharmacology, vol. 60, pp.83-90, 2000.
 S. Schwarze, A. Ho, A. Vocero-Akbani, and S. Dowdy, "In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse," Science, vol. 285, pp. 1569-1572, 1999.
 A. Jones, "Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides," Journal of Cellular and Molecular Medicine, vol. 11, pp. 670-684, 2007.
 S. Mayor and R. Pagano, "Pathways of clathrin-independent endocytosis," Nature Reviews Molecular Cell Biology, vol. 8, pp. 603-612, 2007.
 J. Hoyer and I. Neundorf, "Peptide Vectors for the Nonviral Delivery of Nucleic Acids," Accounts of Chemical Research, vol. 45, pp. 1048-1056,2012.
 U. Koppelhus, T. Shiraishi, V. Zachar, S. Pankratova, and P. Nielsen, "Improved Cellular Activity of Antisense Peptide Nucleic Acids by Conjugation to a Cationic Peptide-Lipid (CatLip) Domain," Bioconjugate Chemistry, vol. 19, pp. 1526-1534, 2008.
 A. Muratovska and M. Eccles, "Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells," Federation of European Biochemical Societies, vol. 558, pp. 63-68, 2004.
 T. Davidson, S. Harel, V. Arboleda, G. Prunell, M. Shelanski, L. Greene, and C. Troy, "Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation," The Journal of Neuroscenice, vol. 24, pp. 10040-6, 2004.
 N. Unnamalai, B. Kang, and W. Lee, "Cationic oligopeptide-mediated delivery of dsRNA for post-transcriptional gene silencing in plant cells," Federation of European Biochemical Societies, vol. 566, pp. 307-310, 2004.
 F. Simeoni, M. Morris, F. Heitz, and G.D. . "Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells," Nucleic Acids Research, vol. 31, pp. 2717-2724, 2003.
 F. Madani, S. Lindberg, Ü. Langel, S. Futaki, and A. Gräslund, "Mechanisms of Cellular Uptake of Cell-Penetrating Peptides," Journal of Biophysics, vol. 2011, p. 414729, 2011.
 M. Yeaman and N. Yount, "Mechanisms of Antimicrobial Peptide Action and Resistance," Pharmacological Reviews, vol. 55, pp. 27-55, 2003.
 J. Hsu and C. Yip, "Molecular Dynamics Simulations of Indolicidin Association with Model Lipid Bilayers," Biophysical Journal, vol. 92, pp. L100-L102, 2007.
 J. Shaw, J. Alattia, J. Verity, G. Privé, and C. Yip., "Mechanisms of antimicrobial peptide action: Studies of indolicidin assembly at model membrane interfaces by in situ atomic force microscopy," Journal of Structural Biology, vol. 154, pp. 42-58, 2006.
 L. Zhang, A Rozek, and R. Hancock, "Interaction of Cationic Antimicrobial Peptides with Model Membranes," Journal of Biological Chemistry, vol. 276, pp. 35714-35722, 2001.
 T. Rokitskaya, N. Kolodkin, E. Kotova, and Y. Antonenko, "Indolicidin action on membrane permeability: Carrier mechanism versus pore formation," Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1808, pp. 91-97, 2011.
 林則緯, "利用穿膜胜肽改善帶正電高分子之轉染效率," 化學工程與材料工程學系, 國立中央大學, 2012.
 D. McKenzie, K. Kwok, and K. Rice, "A Potent New Class of Reductively Activated Peptide Gene Delivery Agents," Journal of Biological Chemistry, vol. 275, pp. 9970–9977, 2000.
 D. Manickam and D. Oupický, "Multiblock Reducible Copolypeptides Containing Histidine-Rich and Nuclear Localization Sequences for Gene Delivery," Bioconjugate Chemistry, vol. 17, pp. 1395-1403, 2006.
 M. Balakirev, G. Schoehn, and J. Chroboczek, "Lipoic acid-derived amphiphiles for redox-controlled DNA delivery," Chemistry & Biology, vol. 7, pp. 813-819.
 M. Read, K. Bremner, D. Oupický, N. Green, P. Searle, and L. Seymour, "Vectors based on reducible polycations facilitate intracellular release of nucleic acids," The Journal of Gene Medicine, vol. 5, pp. 232-245, 2003.
 X. Loh, T. Lee, Q. Dou, and G. Deen, "Utilising inorganic nanocarriers for gene delivery," Biomaterials Science, vol. 4, pp. 70-86, 2016.
 T. Green, J. Fisher, M. Stone, B. Wroblewski, and E. Ingham, "Polyethylene particles of a ‘critical size’ are necessary for the induction of cytokines by macrophages in vitro," Biomaterials, vol. 19, pp. 2297-2302, 1998.
 O. Calonius and V. Saikko, "Analysis of Polyethylene Particles Produced in Different Wear Conditions In Vitro," Clinical Orthopaedics and Related Research, vol. 399, pp. 219-230, 2002.
 Y. Liu, D. Peterson, H. Kimura, and D. Schubert, "Mechanism of Cellular 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) Reduction," Journal of Neurochemistry, vol. 69, pp. 581-593, 1997.
 R. Pan, W. Xu, F. Yuan, D. Chu, Y. Ding, B. Chen, M. Jafari, Y. Yuan, and P. Chen, "A novel peptide for efficient siRNA delivery in vitro and therapeutics in vivo," Acta Biomaterialia, vol. 21, pp. 74-84, 2015.